RE:RE:I'd Like to See a PP at $.25 with Warrants for 1 yr at $.50I tend to believe that TLT has major credibility issues that needs to be addressed for any PP to succeed. Past PP efforts clearly indicate investors are becoming warry of any proposal from the current management to raise more capital while they contiue to keep pushing time-lines further and further. The recent spate of announcements, that have been obviously held back, for maximum effect prior to the AGM is designed to obfuscate rather than offer a clear path to reaching their past stated goals of BTD/AA. FDA is requiring for a central Pathology to re-validate the CSS test results. TLT management needs to address WHY this is being required.